期刊文献+

水飞蓟素对乳腺癌细胞系的作用及其机制研究 被引量:8

Inhibitory effect of silymarin on different breast cancer cell lines and associated molecular mechanism
下载PDF
导出
摘要 目的 研究水飞蓟素在体外对不同乳腺癌细胞系的作用 ,并进一步探讨其作用机制。方法  MTT实验测定水飞蓟素对乳腺癌细胞系 MCF- 7和 SK- BR- 3的半数抑制浓度 ( IC50 ) ;软琼脂克隆形成试验检测加药后两种细胞在软琼脂内的增殖能力。在此基础上 ,用 Her- 2抑制剂 AG82 5进行干预 ,对水飞蓟素的作用机制进行初步探讨。结果 水飞蓟素对两种乳腺癌细胞有不同程度的抑制作用 ,其中对 MCF- 7细胞的作用较强 ,IC50 ≤ 0 .0 2 %,而对SK- BR- 3的作用较弱。 Her- 2抑制剂 AG82 5可增加 SK- BR- 3细胞对药物的敏感性 ,抑制了水飞蓟素作用后该细胞在软琼脂中集落的形成。结论 水飞蓟素在体外对 MCF- 7细胞具有明显的抑制作用 ,而 AG82 5可增强 SK- BR-3细胞对药物的敏感性。因此 ,SK- BR- 3细胞中 Her- 2的高表达可能是该细胞对水飞蓟素敏感性差的原因 ,而水飞蓟素也可能通过 Her- 2调节某个或某几个下游分子起作用。 Object To investigate the anticancer effect of silymarin on different breast cancer cell lines, and approach the molecular mechanism. Methods Two breast cancer cell lines were cultured to study the effect of silymarin on cell growth and proliferation. Firstly, MTT assay was used to evaluate the IC 50 of silymarin on the two cell lines, MCF-7 and SK-BR-3. Secondly, through soft agar assay, the ability of cell proliferation, when exposed to silymarin at various dosages, was detected. Finally, AG825, inhibitor of the protein tyrosine kinase Her-2 was used to intervene the effect of silymarin on SK-BR-3 cells. Results Silymarin could inhibit the growth of MCF-7 and SK-BR-3 cells in vared degrees. MCF-7 cells were very sensitive to the agent, IC 50≤0.02%; while SK-BR-3 cells were less sensitive. Her-2 inhibitor AG825 increased the sensitivity of SK-BR-3 cells to silymarin and inhibited the growth of the cells in soft agar. Conclusion From the above, it could be concluded that silymarin has the cancer chemopreventive and anticancer effects on breast cancer cell lines. It could completely inhibit the growth of MCF-7 cells, and partly of SK-BR-3 cells. AG825 could improve the sensitivity of SK-BR-3 cells to silymarin. Overexpression of Her-2 on the surface of SK-BR-3 cells may be owed to the lower sensitivity to silymarin and silymarin may be possible to affect cell growth through one or more downstream molecules regulated by Her-2.ari
出处 《中草药》 CAS CSCD 北大核心 2003年第3期238-241,共4页 Chinese Traditional and Herbal Drugs
基金 国家自然科学基金资助项目 ( 30 170 46 5 ) 全军医学科研"十五"计划重点课题 ( 0 1Z0 81)
关键词 水飞蓟素 乳腺癌 HER-2 AG825 silymarin breast cancer Her-2 AG825
  • 相关文献

参考文献11

  • 1[1]Bosisio E, Benelli C, Pirola O. Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes [J]. Pharmacol Res,1992, 25: 147-154.
  • 2[2]Muzes G, Deak G, Lang L, et al. Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme [J]. Acta Physiol Hung, 1991, 78:3-9.
  • 3[3]Zi X, Zhang J, Agarwal R, et al. Silibin up-regulates insulinlike growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells [J]. Cancer Res, 2000, 60: 5617-5620.
  • 4[4]Zhao J, Lahiri-Chatterjee M, Sharma Y, et al. Inhibitory effect of a flavonoid antioxidant silymarin on benzol peroxideinduced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin [J]. Carcinogenesis, 2000,21: 811-816.
  • 5[5]Zi X L, Feyes D K, Agarwal R. Antiearcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclines [J]. Clin Cancer Res, 1998, 4: 1055-1064.
  • 6[6]Manna S K, Mukhopadhyay A, Van N T, et al. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-termimal kinase, and apoptosis [J]. J Immunol, 1999, 163:6800-6809.
  • 7[7]Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents [J]. Biochem Pharmacol, 2000, 60: 1051-1059.
  • 8[8]Meric F, Lee W P, Sahin A, et al. Expression protein of tyrosine kinase in breast cancer [J]. Clin Cancer Res, 2002, 8:361-367.
  • 9[9]Kurokawa H, Lenferink A E G, Simpson J F, et al. HER-2/neu (erbB-2) and mitogen-activated protein kinase enhance tamoxifen action against HER-2-overexpressing, tamixifenresistent breast cancer cell [J]. Cancer Res, 2000, 60: 5887-5896.
  • 10[10]Ulrich H, Zong C S, Wang L H. ErbB-2-overexpressing human mammary carcinoma cells displays an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth [J]. Oncogene, 2001, 20:7551-7562.

同被引文献81

引证文献8

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部